| 000 | 01837nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025959.0 | ||
| 008 | 091210s2007 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.05.Ph.D.2007.Sa.E | ||
| 100 | 0 | _aSahar Ahmed Khaleel | |
| 245 | 1 | 0 |
_aEpidemiologic and clinicopathologic study of wilms tumor in children and treatment outcome / _cSahar Ahmed Khaleel ; Supervised Samy A. Elbadawy , Alaa M. Elhadaad , Mohamed Akram Nouh |
| 246 | 1 | 5 | _aدراسة وبائية واكلينيكية باثولوجية لورم ويلمز فى الاطفال ونتائج العلاج |
| 260 |
_aCairo : _bSahar Ahmed Khaleel , _c2007 |
||
| 300 |
_a135P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology | ||
| 520 | _aWilms` tumor is the most common renal malignancy of childhood and represents 6% of childhool cancer . This prospective study included 53 patient with age range between 2 months and 9 years and a median of 3 years with slight male predominance. Abdominal males was the most common presentation 77.4% stage distribtion was 29.4% , 17.6% , 29.4% , 17.6% and for stages I-V respectively . Favorable histology was reported in 86.3% . The 2 years diease free survival was 79% | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aChildren | |
| 653 | 4 | _aProspective study survival rates | |
| 653 | 4 | _aWilms` tumor | |
| 700 | 0 |
_aAlaa Mohamed Elhadaad , _eSupervisor |
|
| 700 | 0 |
_aMohamed Akram Nouh , _eSupervisor |
|
| 700 | 0 |
_aSamy Ahmed Elbadawy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c24831 _d24831 |
||